2023
Catheter Ablation for Ventricular Tachycardia After MI: A Reconstructed Individual Patient Data Meta-analysis of Randomised Controlled Trials
Reddy R, Howard J, Ahmad Y, Shun-Shin M, Simader F, Miyazawa A, Saleh K, Naraen A, Samways J, Katritsis G, Mohal J, Kaza N, Porter B, Keene D, Linton N, Francis D, Whinnett Z, Luther V, Kanagaratnam P, Arnold A. Catheter Ablation for Ventricular Tachycardia After MI: A Reconstructed Individual Patient Data Meta-analysis of Randomised Controlled Trials. Arrhythmia & Electrophysiology Review 2023, 12: e26. PMID: 38124803, PMCID: PMC10731517, DOI: 10.15420/aer.2023.07.Peer-Reviewed Original ResearchCatheter ablationMedical therapyIndividual patient dataCause mortalityPrior MIVT recurrenceDefibrillator shocksIndividual Patient Data Meta-AnalysisVentricular tachycardia catheter ablationReconstructed individual patient dataPrespecified primary endpointPrespecified secondary endpointPatient dataPrespecified subgroup analysisProportion of patientsRandomised Controlled TrialsIndividual patient assessmentData Meta-AnalysisCause hospitalisationPrimary endpointSecondary endpointsPrognostic impactControlled TrialsPatient assessmentSubgroup analysis
2016
97 Multi-vessel Angioplasty at the Time of STEMI has Equivalent Mortality to a Culprit Only Strategy: Resolving The Paradox of Randomised Controlled Trials and Observational Studies in Multivessel Disease and STEMI
Ahmad Y, Cook C, Petraco R, Nijjer S, Al-Lamee R, Shun-Shin M, Keene D, Balu A, Malik I, Baker C, Mikhail G, Sethi A, Foale R, Davies J, Mayet J, Francis D, Sen S. 97 Multi-vessel Angioplasty at the Time of STEMI has Equivalent Mortality to a Culprit Only Strategy: Resolving The Paradox of Randomised Controlled Trials and Observational Studies in Multivessel Disease and STEMI. Heart 2016, 102: a68. DOI: 10.1136/heartjnl-2016-309890.97.Peer-Reviewed Original ResearchHigh-risk patientsLarge observational studiesObservational studyResidual diseaseEquivalent mortalityPrimary percutaneous coronary interventionST-elevation myocardial infarctionMulti-vessel diseasePercutaneous coronary interventionRandomised Controlled TrialsAllocation biasMultivessel diseaseCoronary interventionRisk patientsControlled TrialsMyocardial infarctionSmall RCTsPatientsHigh mortalitySTEMIMortalityDiseaseConflicting resultsRCTsPPCI